Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival

Background: A higher rate of cancer in systemic sclerosis (SSc) is recognized but the role of SSc-linked autoantibodies status (positive/negative and autoantibody specificities) in the survival of SSc-patients with cancer remains poorly understood. Methods: We utilized the Clalit-Health-Services med...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncoimmunology
Autori principali: Watad, Abdulla, McGonagle, Dennis, Bragazzi, Nicola L., Tiosano, Shmuel, Comaneshter, Doron, Shoenfeld, Yehuda, Cohen, Arnon D., Amital, Howard
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2019
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492983/
https://ncbi.nlm.nih.gov/pubmed/31069155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1588084
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi